Important FDA-approved drugs to treat HIV and cancer can save lives, but they come with their own risks. Some drugs used clinically are known to cause neurological side effects in up to half of ...

MONROE COUNTY, Wis. (WEAU) - Another Tomah man is now charged in connection to a drug overdose death. Online court records show 47-year-old James Zinsmeister is charged with 1 st degree reckless ...

Team to develop and validate computational models trained on data from organoids and advanced human model systems that will improve drug safety and reduce reliance on animal testing NEW YORK, Dec. 8, ...

WILLIAMSPORT — A Lycoming County judge has dismissed the most serious homicide counts against the man accused of providing the drug that killed a Williamsport area woman in 2024. Judge William P.

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Chelsea Cirruzzo is a Washington ...

Tracy Beth Høeg, MD, PhD, was named acting director of the FDA’s Center for Drug Evaluation and Research, effective Dec. 3. She succeeds Richard Pazdur, MD, who was appointed director of the CDER on ...

Dec 2 (Reuters) - The U.S. Food and Drug Administration's drug evaluation chief, Richard Pazdur, is set to retire just weeks after taking the new role, a spokesperson for the health regulator said on ...

Please provide your email address to receive an email when new articles are posted on . The FDA appointed Richard Pazdur, MD, as the new director of the agency’s Center for Drug Evaluation and ...

In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of administration to humans, leading to multiple organ failure. Another example, ...

WASHINGTON, Nov 2 (Reuters) - The director of the U.S. Food & Drug Administration's Center for Drug Evaluation and Research was placed on administrative leave on Friday, The New York Times reported on ...

Baker Hughes is pressing ahead with its “comprehensive evaluation” after seeing a top executive leave and after receiving approval from Chart Industries shareholders to move ahead with its $13.6 ...